1. Introduction {#s0005}
===============

African trypanosomosis is a major disease that has ravaged the livestock industry in tropical Africa where disease is endemic [@b0005], [@b0010]. *Trypanosoma congolense, T. vivax* and *T. brucei* remain the major pathogenic tsetse transmitted trypanosome species responsible for the disease in tropical regions of Africa, where the vector *(Glossina spp*) is prevalent [@b0015]. The disease is an haemoparasitic disease of domestic animals with manifestations such as; severe anaemia, weight loss, reduced productivity, infertility and abortion, with death occurring in some animals during the acute and chronic phase [@b0020].

Drugs of therapy and prophylaxis (Chemotherapy and chemoprophylaxis) are the main methods of controlling trypanosomosis [@b0025]. These methods of control are still the most reliable in spite of problems of drug resistance and toxicity [@b0030] especially since the development of an effective vaccine against the disease has been unsuccessful despite intensive effort in research [@b0010]. Diminazene aceturate is one of the few drugs available for both treatment and prophylaxis of African trypanosomosis in livestock especially in cattle infected with *T. congolense, T. vivax* and *T. brucei* [@b0035]. Conventional chemotherapeutic treatment of trypanosomosis is no longer befitting as a result of side effects associated with the drugs and the development of many resistance trypanosome in many part of the world. Research now focuses on new compounds for the treatment of trypanosome infection [@b0040]. One possible source for such affordable treatment lies in the use of natural products which have served as an important source of drugs since ancient times. About half of useful drugs have been derived from natural source [@b0045]. Antiparasitic plant-derived molecules have been used as lead compounds to develop semi-synthetic drugs with better efficacy and safety [@b0050]. Due to the aforementioned reasons and implications this study was aimed at assessing the effect of *Moringa oleifera* on the survivability rate, weight gain and histopathological changes observed during the course of trypanosomosis.

2. Materials and methods {#s0010}
========================

2.1. Ethics, experimental animals and study design {#s0015}
--------------------------------------------------

Ethical approval was sought from Animal Care, Use and Review Ethical Committee (ACUREC), University of Ibadan, Nigeria with approval code number as thus, UI-ACUREC/APP/2016/011

Thirty adult male and female Wistar rats between the ages of 8--12 weeks, weighing from 90 to 105 g were used for this study. The rats were housed in the animal house of the Department of Veterinary Physiology, Biochemistry and Pharmacology, University of Ibadan, Nigeria. The animals were kept in cages under normal environmental temperature (20--22 °C) and fed with standard pelleted feed (Livestock® Lagos, Nigeria) and water given *ad libitum.* The rats were allowed to acclimatize to the laboratory environment for two weeks before the experiment commenced. Rats were grouped into six groups of five rats each and the extracts were administered through the oral route using oral cannula.

The rats were divided into six groups, each comprising five rats and each group was treated as follows: Group A (Negative controls)**,** treated with distil water (uninfected and untreated). Group B**:** *Moringa oleifera* was administered orally at 200 mg/kg daily for 14 days before infection and supplement continued after infection for 16 days. Group C**:** *Moringa oleifera* was administered orally at 200 mg/kg daily for 14 days before infection and treatment stopped after infection. Group D**:** *Moringa oleifera* was administered (daily) orally at 200 mg/kg for 90 days pre-infection and supplement continued after infection for 16 days. Group E: *Moringa oleifera* was administered orally at 200 mg/kg daily for 90 days pre-infection and treatment stopped post-infection. Group F**:** Infected and untreated rats (positive control).

2.2. Plant authentication and preparation {#s0020}
-----------------------------------------

The leaves of *Moringa oleifera* were procured at Ajibode, Akinyele Local Government area of Oyo State, located in the South Western part of Nigeria, which is about 2 Km from University of Ibadan, Ibadan Nigeria. It was taxonomically identified and authenticated in the herbarium of the Department of the Forest Research Institute of Nigeria (FRIN), with voucher number UIH-10847. The leaves of *Moringa oleifera* were washed thoroughly, dried in shade and pulverized to powder. The methalonic extraction was done at the Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Science, University of Ibadan using the method of Adeyemi et al. [@b0020]. The extract was concentrated to the final concentration of 7.5% stock solution using rotary evaporator and the yield was diluted in soya oil as a vehicle.

2.3. Moringa oleifera phytochemical screening {#s0025}
---------------------------------------------

Phytochemical screening of methanol extract of *Moringa oleifera* leaves was subjected to qualitative chemical screening for identification of the various classes of the chemical constituents as previously described by Sofowora [@b0055].

2.4. Trypanosoma stock and inoculation {#s0030}
--------------------------------------

*Trypanosoma brucei* used in this study was secured from Nigeria institute for Trypanosomiasis and Onchocerciasis research institute, Vom, Plateau state, Nigeria. The dose of inoculum was judged to be 3x10^6^ of *Trypanosoma brucei* per mL of blood using the "Rapid Matching method" described by Herbert and Lumsden [@b0060]. The parasites were maintained by serial passage in rats. To infect the rat, 1 ml of blood was collected from heavily infected rat and then melded with 2 ml of normal saline. The mixture was viewed under microscope at X40 magnification. The blood containing the parasites was then injected into rats intraperitoneally

2.5. Weight gain determination {#s0035}
------------------------------

The weights of the rats were monitored from first day and later on weekly basis using automated electronic scale (Sensor Disc Technology, London). To weigh a rat, a round plastic container was placed on the scale and tarred to zero following which the rat was dropped inside the container and subsequently weighed.

2.6. Histological procedures {#s0040}
----------------------------

After the death of the rats, the brain and spleen were extracted from the rats and were adequately treated with 10% formaldehyde (fixation) in order to preserve both the structure and molecular composition [@b0065]. The organs were dehydrated by bathing it successively in rated mixture of ethanol and water (70--100%). The ethanol was replaced with a solvent mixable with the embedding medium. The tissues were penetrated with xylene and it became transparent (clearing). The instilled tissue with xylene was placed in melted paraffin in an oven and was maintained at 58--60 °C (embedding). The heat allowed the solvent to evaporate and the spaces within the tissues became filled with paraffin. The tissue together with its impregnating paraffin hardened following removal from the oven. The sections (5 μm) were then floated on water and transferred to a glass slide and stained with haematoxylin and eosin stains. The slides were viewed under light microscope with magnification X40 [@b0065].

2.7. Data analysis {#s0045}
------------------

All data generated were expressed as mean ± SD. The differences between the groups were analyzed by one-way analysis of variance (ANOVA) followed by Dunnet's post hoc multiple comparison test using Graphpad Prism statistical package, San Diego, Califonia, U.S.A (www.Graphpad.Com). Statistical estimates were made at confidence interval of 95%. Probability Values less or equal to 0.05 (*P* ≤ 0.05) were considered significant.

3. Results {#s0050}
==========

3.1. Findings of phytochemical analysis {#s0055}
---------------------------------------

Phytochemical analysis of methanolic extract of *Moringa oleifera* revealed the presence of flavonoid, tannin, saponin, steroid, phenol carbohydrate and glycoside as stated in [Table 1](#t0005){ref-type="table"}.Table 1The phytochemical constituents of *M. oleifera* leaves.ComponentTestObservationScoringAlkaloidDragendorffsBrownish-red colour+TanninsFerric chlorideBlue ink colour+FlavonoidPew'sRed colour+SaponinFrothingPersistence foam+PhenolBuchardViolet colour+CarbohydrateMolisch'sRed colour+GlycosidesSalkowski'sReddish brown+

3.2. Survivability rate {#s0060}
-----------------------

All the rats infected with *T. brucei* died but the group treated with *moringa oleifera* leaves died at day 17 when compared with the untreated group (positive control) that died at day 15 as shown in [Fig. 1](#f0005){ref-type="fig"}.Fig. 1Survival rate chart of rats infected with *T. brucei* and treated with methanolic extract of *Moringa oleifera* leaves A-Uninfected and untreated; B- *M.Oleifera* alone for 14 days before infection and after infection; C- *M.Oleifera* (14 days) D- M.O for 25 days; E-*M.Oleifera* alone for 90 days before infection and after infection; F-*M.Oleifera* (90 days) and G- Infected and untreated.

3.3. Weight gain {#s0065}
----------------

### 3.3.1. Effect of administration of M.O leaf extract for 14 days before infection {#s0070}

The starting weights are the initial mean weight of the rats in the groups after 2 weeks of acclimatization in the animal house. The mean weights were measured on weekly basis and compared with the control. The weight of rats in group C were found to be statistically significantly higher (*P* \< 0.05) in both first and second week. The percentage weight gain of rats in group B was lower (15.9%) when compared with other groups as stated in [Table 2](#t0010){ref-type="table"}.Table 2Weight changes (%) in rats dosed with methanolic extract of *moringa oleifera* leaves for 14 days.Weight parameterGroup AGroup BGroup CGroup F (+control)Starting weight (grams)98 ± 9.9113 ± 26.6109 ± 19.499.4 ± 12.2Day7 (%changes)107 ± 10.4 (9.2%)121 ± 27.9 (7.1%)126 ± 18.9[a](#tblfn1){ref-type="table-fn"} (15.6%)110.2 ± 18.5 (7.8%)Day14 (%changes)115 ± 10.8 (17.2%)131 ± 30.6 (15.9%)135 ± 19.4[a](#tblfn1){ref-type="table-fn"} (23.9%)119.2 ± 16.7 (16.7%)[^1][^2]

### 3.3.2. Effect of administration of *M.O.* leaf extract for 90 days before infection {#s0075}

On the 90th day, the final weight was compared with the controls (groups A and F). The weight of rats in group D were found to be significantly lower (*P* \< 0.05) at day 21, 42, 76 and 83 while the weight of rats in group E were found to be significantly lower (*P* \< 0.05) at day 56, 76 and 83. The rats in groups (D and E) treated with *Moringa oleifera* leaves had percentage weight gain of 64.3% and 60.3% respectively when compared with the controls (A and F) that had 71.8 and 70.6 respectively ([Table 3](#t0015){ref-type="table"}).Table 3Weight changes (%) in rats dosed with methanolic extract of *moringa oleifera* leaves for 90 days.Weight parameterGroup A (control)Group DGroup EGroup F (+control)Starting weight (grams)98.3 ± 9.998.2 ± 22.1100.3 ± 12.299.4 ± 12.2Day7 (%changes)107.2 ± 10.4 (9.2%)103.7 ± 25.2 (5.1%)106.2 ± 14.7 (6%)110.2 ± 18.5 (7.8%)Day 14115.6 ± 10.8 (17.3%)108 ± 26.6 (10.2%)111.5 ± 12.6 (11%)119.2 ± 16.7 (16.7%)Day 21122 ± 9.5 (24.5%)113.3 ± 28.4[b](#tblfn2){ref-type="table-fn"} (15.3%)118.4 ± 13.1 (18%)125.1 ± 20.1 (22.5%)Day 28128 ± 9.9 (30.6%)118 ± 27.9 (20.4%)125 ± 12.2 (25%)131 ± 22.1 (28.4%)Day 35131.4 ± 9.9 (33.6%)124 ± 33.3 (26.5%)131.7 ± 13.1 (31%)137 ± 24.3 (34.3%)Day 42135.8 ± 13.1 (37.7%)130 ± 40.1[b](#tblfn2){ref-type="table-fn"} (32.7%)134.1 ± 16.2 (34%)142.4 ± 27.9 (39.2%)Day 49139.1 ± 20.3 (41.8%)137.2 ± 51.8 (39.8%)138 ± 15.3 (38%)147.3 ± 30.2 (44.1%)Day 56148 ± 22.1 (47.9%)143.3 ± 61.2 (42.9%)144.1 ± 20.7 (41%)153.5 ± 31.5 (48%)Day 63148 ± 22.1143.3 ± 61.2144.1 ± 20.7153.5 ± 31.5(51%)(45.9%)(44.1%)(50%)Day 70152 ± 22.1145.4 ± 61.7146 ± 21.2157.1 ± 33.8(58.2%)(47.9%)(46%)(53.9%)Day 77161.6 ± 18.0149.1 ± 62.1[b](#tblfn2){ref-type="table-fn"}148.4 ± 22.1[b](#tblfn2){ref-type="table-fn"}160 ± 34.7(64.3%)(52%)(48.4%)(56.9%)Day 84172 ± 23.9153 ± 63.9[b](#tblfn2){ref-type="table-fn"}152.1 ± 22.5[b](#tblfn2){ref-type="table-fn"}166.4 ± 35.1(67.5%)(56.1%)(52%)(62.7%)Day 90188 ± 24.8161 ± 66.2 (64.3%)160.3 ± 23.9174.6 ± 35.6(71.8%)(60.3%)(70.6%)[^3][^4]

3.4. Histopathological findings {#s0080}
-------------------------------

The Photomicrograph of brain in rats (Group F) that are infected and untreated showed multiple foci of neuronal degeneration, marked proliferation of oligodendroglia and neuropil vacuolation**,** moderate congestion of cerebral blood vessels ([Fig. 2](#f0010){ref-type="fig"}a) while that of rats uninfected and untreated (Group A) appeared normal with no visible lesion ([Fig. 2](#f0010){ref-type="fig"}b). Photomicrograph of brain in rats treated with M.O for 14 days before trypanosomal infection also appeared normal although, there is moderate congestion of cerebral blood vessels ([Fig. 3](#f0015){ref-type="fig"}a) while that of rats treated with M.O 14 days pre-infection and continued post-infection had no visible lesion ([Fig. 3](#f0015){ref-type="fig"}b). However, the photomicrograph of brain in rats treated with M.O 90 days pre-infection had few foci of neuronal degeneration and necrosis, moderate swelling of endothelial cells of the cerebral blood vessels as well as congestion of the blood vessels ([Fig. 4](#f0020){ref-type="fig"}a) while that of group treated with M.O for 90 days pre-infection and continued post-infection had multiple foci of neuronal degeneration and marked proliferation of glia cells as well as vacuolation of the neuropil ([Fig. 4](#f0020){ref-type="fig"}b).Fig. 2(a) Photomicrograph of brain in the infected and untreated rats showing multiple foci of neuronal degeneration (blue arrows), marked proliferation of oligodendroglia, neuropil vacuolation and moderate congestion of cerebral blood vessels (×40, H&E). (b) Photomicrograph of brain in uninfected and untreated rats showing normal neurons (arrow) and neuropil (star) with no visible lesion (×40, H&E).Fig. 3(a) Photomicrograph of brain in rats treated with M.O (14 days pre-infection) showing normal neurons and neutrophil with moderate congestion of cerebral blood vessels (arrows) (×40, H&E). (b) Photomicrograph of brain in rats treated with M.O (14 days pre-infection and continued post-infection) showing normal neurons (arrow) and neuropil (star) with no visible lesion (×40, H&E).Fig. 4(a) Photomicrograph of brain in rats treated with M.O for 90 days pre-infection showing few foci of neuronal degeneration and necrosis (black arrows), moderate swelling of endothelial cells of the cerebral blood vessels as well as congestion of the blood vessels (blue arrow) (×40, H&E). (b) Photomicrograph of brain in rats treated with M.O (90 days pre-infection and continued post-infection) showing multiple foci of neuronal degeneration and marked proliferation of glia cells (blue arrows) as well as vacuolation of the neuropil (black arrows) (×40, H&E).

The different histopathologies in the spleen as a result of Trypanosomal infection either with acute or chronic treatment with methanolic extract of M.O pre-infection only or pre and post-infection are shown in [Fig. 5](#f0025){ref-type="fig"}, [Fig. 6](#f0030){ref-type="fig"}, [Fig. 7](#f0035){ref-type="fig"}.Fig. 5(a) Photomicrograph of spleen in untreated and uninfected rats showing moderate numbers of fairly-large PALSs (star), congestion of the splenic sinuses and sinusoids (×40, H&E). (b) Photomicrograph of spleen in infected and untreated rats showing numerous large discrete to coalescing PALSs (thick arrows), moderate congestion of the splenic sinuses and sinusoids and multiple foci of macrophages laden with golden brown pigments \[haemosiderosis\] (thin arrows). Findings are suggestive of intense lymphoid proliferation (×40, H&E).Fig. 6(a) Photomicrograph of spleen in rats treated with M.O (14 days pre-infection) showing few large discrete PALSs (star), marked congestion of the splenic sinuses and sinusoids, and multiple foci of macrophages laden with golden brown pigments \[haemosiderosis\] (thin arrows) (×40, H&E) (b) Photomicrograph of spleen in rats treated with M.O (14 days pre-infection and continued post-infection) showing moderate numbers of large discrete PALSs (thick arrow), marked congestion of the splenic sinuses and sinusoids and multiple foci of macrophages laden with golden brown pigments \[haemosiderosis\] (thin arrows) (×40, H&E).Fig. 7(a) Photomicrograph of spleen in rats treated with M.O (90 days pre-infection) showing few numbers of discrete small PALSs (thick arrows), marked congestion of the splenic sinuses and sinusoids (blue arrow), and multiple foci of macrophages laden with golden brown pigments \[haemosiderosis\] (black arrows) (×40, H&E). (b) Photomicrograph of spleen in rats treated with M.O (90 days pre-infection and continued post-infection) showing severe lymphoid depletion and lymphocytolysis (black arrows), moderate congestion of the splenic sinuses and sinusoids, and multiple foci of haemosiderin-laden macrophages (blue arrows) (×40, H&E).

4. Discussion {#s0085}
=============

The qualitative phytochemical screening of the methanolic extract of *moringa oleifera* leaves used in this study indicated the presence of tannins, alkaloid, flavonoid, saponin and glycosides. This is in line with previous work described by other workers that analyze the phytochemical component of *moringa oleifera* as a medicinal plant [@b0070]

The study revealed that *Moringa oleifera* leaves increase the survival rate of infected rats for extra two days when compared with the positive control that died at day 15. This showed that methanolic extract of *M. oleifera* leaves does not possess trypanocidal activities against rats infected with *T. brucei* as earlier concluded in the work of Atawodi et al. [@b0075] which reported that different parts of *M. oleifera* possess anti-trypanocidal effect against different species of trypanosome such as *T. brucei* and *T. congolensis.*

The outcome of percentage weight gain in this study showed that *Moringa oleifera* leaves improve the percentage weight gain on acute dosing (14 days) as observed in 23% weight gain when compare with 17% observed in the negative control group. On the other hand, in chronic dosing (90 days) there was a decrease in percentage weight gain (63%) as against 73% seen in the negative control group. This decrease in percentage weight gain may be as a result of presence of tannins which produce anti-nutritive effects thereby reducing feed consumption. This is in accordance with the work of Awotunde et al. [@b0080] that reported that *Moringa oleifera* reduces feed consumption when used for long term. The *Trypanosome brucei* DNA is mainly present in the brain of animal at day 6 post-infection and increase more than 15-fold on reaching day 21. Parasites and T-cells are observed in the parenchyma from day 9 onwards. Parasites traversing blood vessel walls may also be seen in the hypothalamus and other brain regions and the body weight gain will significantly reduce from day 7 onwards [@b0085], [@b0090]**.**

Trypanosome parasites penetrate the brain leading to vascular degeneration [@b0095]. The histopathological lesions seen in the brain of infected and untreated group are in agreement with Weber [@b0095]. The brain histopathology of the groups with acute administration of *Moringa oleifera* extracts (groups B and C) had lower neuronal degeneration and the neurons appear normal with no visible lesion especially the group B. The result of this study further emphasized that methanolic extract of *Moringa oleifera* leaves is a potent ameliorative agent that reduces neuronal degeneration in the brain of rats infected with *T. brucei* [@b0100], [@b0105]. However, the groups with chronic administration of *Moringa oleifera* extracts (D and E) showed histopathological lesions compared with positive control (Group F). This may be as a result of excessive antioxidant effect of *Moringa oleifera* extracts that in turned lead to prooxidant effects [@b0110].

Splenomegaly was a prominent feature of infection with both *T. brucei* and *T. congolensis* [@b0115]. This is associated with acute or parasitemic phase of trypanosome infection and attributed its cause to red blood cell sequestration and expanded macrophage population [@b0115], [@b0120]. The hyperplasia of germinal center and proliferation of macrophages and plasma cells observed in this study are in agreement with Clyton et al. [@b0110] who reported increase in splenic macrophages and the profound effects of trypanosomes on mature splenic lymphocytes. The presence of trypanosomes has been demonstrated to stimulate and cause proliferation of splenic B-lymphocytes [@b0125]. Some of the proliferating B-cells differentiate and secretes large amount of immunoglobulins of diverse specificity [@b0130]. The proliferation of immune competent splenic cells may be responsible for prominent increase size following infection with *T. brucei*. Treatment using *Moringa oleifera* gave variable results regarding response of the spleen to treatment. It is however difficult to compare this observation with those of other workers as a result of dearth of data on *Moringa oleifera* supplementation following trypanocide treatment in trypanosomosis albeit Aremu et al., [@b0115] reported that methanolic extract of *M. oleifera* potentiates diamenazine aceturate in the treatment of trypanosomosis. The photomicrographs of spleen in this study showed marked congestion of the splenic sinuses and sinusoids suggesting marked splenic depletion. This is as a result of erythrocytes destruction by the trypanosome organisms which is in line with the report of a previous work [@b0130] that showed the pathogenesis of anaemia in *T. congolensis* infected mice. The congestion in the spleen in *M. oleifera* treated group was considerably reduced when compared with the positive control group. This result is in line with report of the findings of Shetty and Naryana [@b0135] that compared the histopathology in rats infected with *T. brucei*.

5. Conclusions {#s0090}
==============

The study revealed that *Moringa oleifera* supplement for short period of time (1--14 days) improves the weight gain but when administered for long time (90--100 days), the weight will be reduced. The study also deduced that *Moringa oleifera* supplement reduces tissue and organ damage caused during trypanosomal infection and this is as a result of the potent antioxidant effect of the crude extract. It can also be concluded that *M. oleifera* improves survivability of rats infected with *Trypanosoma* spp.
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